Latest Insider Transactions at Oyster Point Pharma, Inc. (OYST)
This section provides a real-time view of insider transactions for Oyster Point Pharma, Inc. (OYST). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oyster Point Pharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oyster Point Pharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 18
2021
|
Clare Ozawa Director |
SELL
Open market or private sale
|
Indirect |
550,000
-22.86%
|
$7,700,000
$14.86 P/Share
|
Oct 18
2021
|
William J Phd Link Director |
SELL
Open market or private sale
|
Indirect |
550,000
-22.86%
|
$7,700,000
$14.86 P/Share
|
Oct 18
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
550,000
-22.86%
|
$7,700,000
$14.86 P/Share
|
Sep 02
2021
|
Daniel Lochner Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+13.13%
|
$82,500
$11.51 P/Share
|
Sep 01
2021
|
Jeffrey Nau President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+14.1%
|
$10,000
$1.02 P/Share
|
Jul 30
2021
|
Donald J Santel Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,114
+36.95%
|
-
|
Jul 28
2021
|
Daniel Lochner Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+15.11%
|
$82,500
$11.51 P/Share
|
Jun 07
2021
|
Michael G Atieh Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+13.02%
|
-
|
Jun 07
2021
|
William J Phd Link Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+25.61%
|
-
|
Jun 07
2021
|
Mark Anthony Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+2.84%
|
-
|
Jun 07
2021
|
Benjamin Tsai Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+25.61%
|
-
|
Jun 07
2021
|
Aimee S Weisner Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+9.46%
|
-
|
Jun 07
2021
|
Ali Behbahani Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+25.61%
|
-
|
Jun 07
2021
|
George Christopher Eliades Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+12.15%
|
-
|
Jun 07
2021
|
Clare Ozawa Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+24.25%
|
-
|
May 12
2021
|
William J Phd Link Director |
BUY
Other acquisition or disposition
|
Indirect |
10,944
+33.43%
|
-
|
May 12
2021
|
Clare Ozawa Director |
SELL
Other acquisition or disposition
|
Indirect |
404,844
-46.12%
|
-
|
May 12
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Direct |
193
+2.56%
|
-
|
May 12
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Indirect |
82,486
+50.0%
|
-
|
May 12
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
404,844
-46.12%
|
-
|
May 12
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
82,486
+50.0%
|
-
|
Apr 02
2021
|
George Christopher Eliades Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,585
+28.55%
|
-
|
Apr 02
2021
|
Jeffrey Nau President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.42%
|
$10,000
$1.02 P/Share
|
Mar 26
2021
|
Clare Ozawa Director |
SELL
Other acquisition or disposition
|
Indirect |
404,849
-44.0%
|
-
|
Mar 26
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Direct |
193
+2.62%
|
-
|
Mar 26
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Indirect |
82,491
+50.0%
|
-
|
Mar 26
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
404,849
-44.0%
|
-
|
Mar 26
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
82,491
+50.0%
|
-
|
Mar 26
2021
|
William J Phd Link Director |
BUY
Other acquisition or disposition
|
Indirect |
10,933
+50.0%
|
-
|
Feb 24
2021
|
Daniel Lochner Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,109
+20.83%
|
$100,199
$11.51 P/Share
|
Feb 19
2021
|
Jeffrey Nau President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+19.65%
|
$10,000
$1.02 P/Share
|
Feb 17
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Direct |
372
+5.07%
|
-
|
Feb 17
2021
|
Clare Ozawa Director |
SELL
Other acquisition or disposition
|
Indirect |
337,107
-70.9%
|
-
|
Feb 17
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Indirect |
12,107
+50.0%
|
-
|
Feb 17
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
12,107
-100.0%
|
-
|
Feb 17
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
12,107
+50.0%
|
-
|
Feb 17
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
325,000
-12.69%
|
-
|
Jan 29
2021
|
Daniel Lochner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,222
+30.54%
|
-
|
Jan 29
2021
|
Jeffrey Nau President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
25,898
+45.6%
|
-
|
Jan 29
2021
|
John Snisarenko Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,222
+38.11%
|
-
|
Dec 10
2020
|
William J Phd Link Director |
BUY
Other acquisition or disposition
|
Indirect |
27,942
+50.0%
|
-
|
Dec 10
2020
|
William J Phd Link Director |
SELL
Other acquisition or disposition
|
Indirect |
955,392
-100.0%
|
-
|
Oct 08
2020
|
Michael G Atieh Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,695
+34.13%
|
-
|
Nov 04
2019
|
Kleiner Perkins Caufield & Byers Xiv, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
45,529
+11.01%
|
-
|